A Cross-over Study to Evaluate the Effect of Itraconazole and Rifampicin on the Pharmacokinetics (PK) of GSK525762 in Healthy Female Subjects of Non Child Bearing Potential

NCT02706535 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Drug Interactions
Neoplasms

Interventions

DRUG: GSK525762 Besylate Tablets
DRUG: Itraconazole 200 mg
DRUG: Rifampicin 300 mg

Sponsor

GlaxoSmithKline